home / stock / numif / numif articles
The emerging psychedelics industry is expanding rapidly across the globe. With research demonstrating promising therapeutic potential for substance...
Defense Dept. Funds Ketamine Study For PTSD Treatment A DOD Health Agency-funded adaptive platform trial for alternative treatments for ...
Psychedelic therapy clinic provider Numinus Wellness (TSX:NUMI) (OTC: NUMIF) announced fourth quarter and full year fiscal 2023 resu...
NY-based strategic consulting firm Research Nester launched global market research for psychedelic substances with projections until 2035...
News, Short Squeeze, Breakout and More Instantly...
Numinus Wellness Inc. Company Name:
NUMIF Stock Symbol:
OTCMKTS Market:
Numinus Wellness Inc. Website:
Numinus Wellness Inc. Announces Third Quarter Fiscal 2024 Results Canada NewsWire Q3 Fiscal 2024 Highlights Revenue of $4.3 million , a 1.9% decline over Q2 2024 Gross profit of $1.0 million , a 9.8% decline over Q2 2024 Cash position of $3.7 million ...
Numinus to Host Q3 Fiscal 2024 Results Conference Call on July 11, 2024 Canada NewsWire VANCOUVER, BC , July 10, 2024 /CNW/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQX: NUMIF), a mental health care company advancing tradition...
Numinus Wellness Announces Resignation of Director Canada NewsWire VANCOUVER, BC , June 24, 2024 /CNW/ - Numinus Wellness Inc. (" Numinus " or the " Company ") (TSX: NUMI) (OTCQX: NUMIF) (FSE: LR23), a mental healthcare company advancing traditional a...